Asia MEK falls to 11-week low; bearish sentiment persists

Methyl ethyl ketone (MEK) spot prices in Asia have declined by around 17-19% over 11 weeks on the back of perpetual high inventory levels, with bearish sentiment expected to prevail in the coming weeks.
Data on 7 June showed prices at $965/tonne CFR (cost & freight) NE (northeast) Asia, $990/tonne CFR SE (southeast Asia), and $980/tonne CFR India.
These prices fell from highs of $1,190/tonne CFR NE and SE Asia and $1,175/tonne CFR India on 29 March.

Consumer sentiment in the region is seeing no sign of improvement amid the prolonged US-China trade spat.
MEK’s main application is as a low-boiling solvent, with half of global demand derived from the paints and coatings industry.
This is particularly apparent in the Chinese domestic market, where downstream manufacturers have been buying on a hand-to-mouth basis, in what is supposed to be the peak demand period for solvents.
Consequently, Chinese suppliers have been trying export to more material out to the rest of Asia, with very little result.
"Downstream users only buy on a need-to basis nowadays." a southeast Asian importer said.
Market players in Asia agreed that buyers in their domestic markets were also reluctant to stock up on their inventories, amid a general fear of an economic downturn.
Importers/traders were not interested in bulk MEK material, even with attractive offers from suppliers.

A bulk offer late on 10 June was quoted at $930/tonne CFR SE Asia for H1 July loading.
Producers and traders remained broadly open to revising down their offers amid ample supplies.
Market players are hopeful of a positive turn in market sentiment late this month.
US President Donald Trump and China President Xi Jinping are supposed to meet to resolve their trade dispute during the G20 summit in Osaka, Japan, on 28-29 June 2019.
Other market players were not so optimistic of a positive outcome in the US-China talks.
"It would still be the same old story, with tensions unsolved." said a Chinese trader.
Looking for chemical products? Let suppliers reach out to you!
2026-07-17
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Asia's MEK sentiment mixed after Golden Week
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
-
India Targets Fake Drug Packaging
-
FDA Warning Letters Put GMP Back in Focus
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
India’s Pharma Cost Problem Gets Worse
-
A Faster Route to Diabetes Drug Chemistry
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Vertex Buys Crinetics for $10 Billion: Rare Disease M&A Is Back
Recommend Reading
-
NHU and Sinopec Advance Liquid Methionine Project
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Aficamten Beats Metoprolol in Obstructive HCM, Strengthening Case Ahead of FDA Decision
-
AstraZeneca Targets Year-End Filing for Novel Hypertension Drug Baxdrostat
-
FDA Clears Sanofi’s Wayrilz (rilzabrutinib) for Adult ITP; U.S. Launch in September
-
MTBE Market Prices Decline
-
DMF Market Consumption Slows Down, Prices Trade in a Narrow Range
-
Bearish Factors Dominate, Adipic Acid Prices Decline
-
Supply and Demand Game, Melamine Market in China Stabilizes and Observes
-
Iran Fully Halts Petrochemical Exports as the Middle East Supply System Faces Restructuring